| Website | constellationphar... |
| Category | BioTech |
| Phone | 617-864-0676 |
| Employees | |
| Description | Epigenetic research |
| Total | $132M |
| Series B, 8/09 Third Rock Ventures The Column Group Venrock Altitude Life Science Ventures | $17.2M |
| Series B, 6/10 SR One Altitude Life Science Ventures Third Rock Ventures Venrock The Column Group | $4.8M |
| Series B, 6/11 Third Rock Ventures The Column Group Venrock Associates SR One Altitude Life Science Ventures | $15M |
| Unattributed, 1/12 Genentech | $95M |
Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.